Marijuana Rescheduling Could Reduce Taxes for U.S. Operators
The U.S. has rescheduled medical marijuana from Schedule I to Schedule III, reducing tax burdens for multi-state operators. This change does not legalize recreational use or benefit all marijuana stocks equally. Key beneficiaries include Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis.
Topics: marijuana rescheduling medical marijuana pot stocks Schedule III classification tax implications